Kaltseis J, Rainer J, De Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med Mycol. 2009;47(4):398–405.
Panackal AA, Marr KA. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med. 2004;25(2):171–81.
Schwarz C, Brandt C, Melichar V, Runge C, Heuer E, Sahly H, et al. Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis. J Cyst Fibros. 2019;18(2):227–32.
Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F et al. Occurrence and relevance of filamentous fungi in respiratory secretion s of patients with cystic fibrosis–a review. Med Mycol.47(4):387–97.
Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis. 2014;16(4):578–87.
Troke P, Aguirrebengoa K, Arteaga C, Ellis D, Heath CH, Lutsar I, et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother. 2008;52(5):1743–50.
Horré R, Schumacher G, Marklein G, Stratmann H, Wardelmann E, Gilges S, et al. Mycetoma due to Pseudallescheria boydii and co-isolation of Nocardia abscessus in a patient injured in road accident. Med Mycol. 2002;40(5):525–7.
Ogawa S, Inoue T, Sugita K. Pseudallescheria boydii infection associated with IgG4-related disease. Eur J Dermatology: EJD. 2022;32(5):653–5.
Cumbo-Nacheli G, de Sanctis J, Holden D. Pseudallescheria Boydii pneumonia in an immunocompetent host. Am J case Rep. 2012;13:163–5.
Chaney S, Gopalan R, Berggren RE. Pulmonary pseudallescheria boydii infection with cutaneous zygomycosis after near drowning. South Med J. 2004;97(7):683–7.
Gottesman-Yekutieli T, Shwartz O, Edelman A, Hendel D, Dan M. Pseudallescheria boydii infection of a prosthetic hip joint–an uncommon infection in a rare location. Am J Med Sci. 2011;342(3):250–3.
Guber I, Bergin C, Majo F. Repeated Intrastromal injections of Voriconazole in combination with corneal debridement for recalcitrant fungal keratitis – a Case Series. Klin Monatsbl Augenheilkd. 2016;233(4):369–72.
Hornbeek H, Ackerman BH, Reigart CL, Stair-Buchmann M, Guilday RE, Patton ML, et al. Pseudallescheria boydii infection of the brain. Surg Infect. 2012;13(3):179–80.
Lavy D, Morin O, Venet G, Maugars Y, Prost A, Berthelot JM. Pseudallescheria boydii knee arthritis in a young immunocompetent adult two years after a compound patellar fracture. Joint bone Spine. 2001;68(6):517–20.
Lopes JO, Alves SH, Benevenga JP, Salla A, Khmohan C, Silva CB. Subcutaneous pseudallescheriasis in a renal transplant recipient. Mycopathologia. 1994;125(3):153–6.
Mursch K, Trnovec S, Ratz H, Hammer D, Horré R, Klinghammer A, et al. Successful treatment of multiple pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode. Child’s Nerv System: ChNS : Official J Int Soc Pediatr Neurosurg. 2006;22(2):189–92.
Zeng C, Ma YS, Zhou JY, Xue CB, Xiong Y, Zhou W, et al. Donor-derived transmission of scedosporiosis in kidney transplant recipients from a systemic lupus erythematosus donor. Curr Med Sci. 2023;43(2):417–20.
Shu T, Green JM, Orihuela E. Testicular involvement in disseminated fungal infection by Pseudallescheria Boydii. Urology. 2004;63(5):981–2.
Tsuji G, Takei K, Takahara M, Matsuda T, Nakahara T, Furue M, et al. Cutaneous pseudallescheria boydii/Scedosporium apiospermum complex infection in immunocompromised patients: a report of two cases. J Dermatol. 2017;44(9):1067–8.
Horton CK, Huang L, Goozé L. Pseudallescheria boydii infection in AIDS. J Acquir Immune Defic Syndr Hum Retrovirology: Official Publication Int Retrovirology Association. 1999;20(2):209–11.
Ishii S, Hiruma M, Hayakawa Y, Sugita T, Makimura K, Hiruma M, et al. Cutaneous pseudallescheria boydii/Scedosporium apiospermum complex (molecular type: Scedosporium apiospermum [Clade 4]) infection: a Case Report and Literature Review of cases from Japan. Med Mycol J. 2015;56(4):E25–30.
Enshaieh SH, Darougheh A, Asilian A, Iraji F, Shahmoradi Z, Yoosephi A, et al. Disseminated subcutaneous nodules caused by Pseudallescheria boydii in an atopic patient. Int J Dermatol. 2006;45(3):289–91.
Khan FA, Hashmi S, Sarwari AR. Multiple subcutaneous mycetomas caused by Pseudallescheria boydii: response to therapy with oral potassium iodide solution. J Infect. 2010;60(2):178–81.
Verweij PE, Cox NJ, Meis JF. Oral terbinafine for treatment of pulmonary pseudallescheria boydii infection refractory to itraconazole therapy. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol. 1997;16(1):26–8.
Kanafani ZA, Comair Y, Kanj SS. Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol. 2004;23(11):836–40.
Taravella MJ, Johnson DW, Petty JG, Keyser RB, Foster CS, Lundberg BE. Infectious posterior scleritis caused by Pseudallescheria boydii. Clinicopathologic findings. Ophthalmology. 1997;104(8):1312–6.
Ginter G, de Hoog GS, Pschaid A, Fellinger M, Bogiatzis A, Berghold C, et al. Arthritis without grains caused by Pseudallescheria Boydii. Mycoses. 1995;38(9–10):369–71.
Lonser RR, Brodke DS, Dailey AT. Vertebral osteomyelitis secondary to Pseudallescheria Boydii. J Spinal Disord. 2001;14(4):361–4.
Apostolova LG, Johnson EK, Adams HP. Jr. Disseminated pseudallescheria boydii infection successfully treated with voriconazole. J Neurol Neurosurg Psychiatry. 2005;76(12):1741–2.
Nesky MA, McDougal EC, Peacock JE Jr. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2000;31(3):673–7.
Ortmann C, Wüllenweber J, Brinkmann B, Fracasso T. Fatal mycotic aneurysm caused by Pseudallescheria boydii after near drowning. Int J Legal Med. 2010;124(3):243–7.
Bradley JC, Hirsch BA, Kimbrough RC 3rd, McCartney DL. Pseudallescheria boydii keratitis. Scand J Infect Dis. 2006;38(11–12):1101–3.
Stonesifer CJ, Khaleel AE, Garcia-Saleem TJ, Husain S, Geskin LJ. Isolated cutaneous pseudallescheria boydii abscess in an immunocompetent man. JAAD case Rep. 2022;21:160–4.
Lainscak M, Hocevar A, Logar D, Beović B, Matos T, Tomsic M. Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient. Clin Rheumatol. 2007;26(6):1023–4.
Ruinemans GM, Haagsma CJ, Hendrix R. Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite. J Clin Rheumatology: Practical Rep Rheumatic Musculoskelet Dis. 2011;17(7):363–4.
Oh IK, Baek S, Huh K, Oh J. Periocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide. Graefe’s Archive Clin Experimental Ophthalmol = Albrecht Von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie. 2007;245(1):164–6.
Alpaydın S, Güler A, Çelebisoy N, Polat SH, Turhan T. Pseudallescheria boydii infection of the central nervous system: first reported case from Turkey. Acta Neurol Belgica. 2015;115(3):489–92.
Bloom PA, Laidlaw DA, Easty DL, Warnock DW. Treatment failure in a case of fungal keratitis caused by Pseudallescheria Boydii. Br J Ophthalmol. 1992;76(6):367–8.
Buzina W, Feierl G, Haas D, Reinthaler FF, Holl A, Kleinert R, et al. Lethal brain abscess due to the fungus scedosporium apiospermum (teleomorph pseudallescheria boydii) after a near-drowning incident: case report and review of the literature. Med Mycol. 2006;44(5):473–7.
Wang XY, Yu SL, Chen S, Zhang WH. CNS infection caused by Pseudallescheria boydii in a near-drowning traveller from a traffic accident. J Travel Med. 2016;23(2):tav018.
Cardoso JC, Serra D, Cardoso R, Reis JP, Tellechea O, Figueiredo A. Cutaneous pseudallescheria boydii infection in a renal transplant patient: a case report. Dermatol Online J. 2009;15(10):8.
Goldberg SL, Geha DJ, Marshall WF, Inwards DJ, Hoagland HC. Successful treatment of simultaneous pulmonary pseudallescheria boydii and aspergillus terreus infection with oral itraconazole. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 1993;16(6):803–5.
Gatto J, Paterson D, Davis L, Lockwood L, Allworth A. Vertebral osteomyelitis due to Pseudallescheria Boydii. Pathology. 1997;29(2):238–40.
Bonduel M, Santos P, Turienzo CF, Chantada G, Paganini H. Atypical skin lesions caused by Curvularia sp. and pseudallescheria boydii in two patients after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;27(12):1311–3.
Busaba NY, Poulin M. Invasive pseudallescheria boydii fungal infection of the temporal bone. Otolaryngology–head neck Surgery: Official J Am Acad Otolaryngology-Head Neck Surg. 1997;117(6):S91–4.
Poza G, Montoya J, Redondo C, Ruiz J, Vila N, Rodriguez-Tudela JL, et al. Meningitis caused by Pseudallescheria boydii treated with voriconazole. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2000;30(6):981–2.
Malinowski MJ, Halandras P. Arterial reconstruction for atypical mycotic aneurysms. Vasc Endovascular Surg. 2013;47(1):45–7.
Pether JV, Jones W, Greatorex FB, Bunting W. Acute pyogenic pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole. J Infect. 1992;25(3):335–6.
Ginter G, Petutschnig B, Pierer G, Soyer HP, Reischle S, Kern T, et al. Case report. Atypical cutaneous pseudallescheriosis refractory to antifungal agents. Mycoses. 1999;42(7–8):507–11.
Oloruntoba OO, Moylan CA. Gender-based disparities in access to and outcomes of liver transplant ation. World J Hepatol.7(3):460–7.
Natale P, Hecking M, Kurnikowski A, Scholes-Robertson N, Carrero JJ, Wong G et al. Perspectives of nephrologists on gender disparities in Access to Kidne Y Transplantation. Clin J Am Soc Nephrol.18(10):1333–42.
Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 2012;56(5):2635–42.
Gilgado F, Serena C, Cano J, Gené J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother. 2006;50(12):4211–3.
Lackner M, Hagen F, Meis JF, van den Gerrits AH, Vu D, Robert V, et al. Susceptibility and diversity in the therapy-refractory genus scedosporium. Antimicrob Agents Chemother. 2014;58(10):5877–85.
Hoenigl M, Salmanton-Garcia J, Walsh TJ, Nucci M, Neoh CF, Jenks JD, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis. 2021;21(8):e246–57.
Martin-Vicente A, Guarro J, González GM, Lass-Flörl C, Lackner M, Capilla J. Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis. J Antimicrob Chemother. 2017;72(4):1118–22.
Carrillo AJ, Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother. 2001;45(7):2151–3.
Lackner M, Rezusta A, Villuendas MC, Palacian MP, Meis JF, Klaassen CH. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates. Mycoses. 2011;54(Suppl 3):12–21.
Add Comment